AUVELITY FDA approval date

The FDA approved AUVELITY on 18 Aug 2022.

FDA approval date
18 Aug 2022

Drug identity has not yet been verified against registry records

Also recorded as BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-08-18DayAUVELITYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215430", "applicant_as_listed_by_fda": "AXSOME", "brand_names": ["AUVELITY"], "active_ingredients": ["BUPROPION HYDROCHLORIDE", "DEXTROMETHORPHAN HYDROBROMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220818", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026